IS4092A - Vatnsuppleysanlegar Camptothecin afleiður og aðferð til framleiðslu þeirra - Google Patents

Vatnsuppleysanlegar Camptothecin afleiður og aðferð til framleiðslu þeirra

Info

Publication number
IS4092A
IS4092A IS4092A IS4092A IS4092A IS 4092 A IS4092 A IS 4092A IS 4092 A IS4092 A IS 4092A IS 4092 A IS4092 A IS 4092A IS 4092 A IS4092 A IS 4092A
Authority
IS
Iceland
Prior art keywords
production
water
camptothecin derivatives
soluble camptothecin
soluble
Prior art date
Application number
IS4092A
Other languages
English (en)
Inventor
Lackey Karen
Joseph Luzzio Michael
Glenn Evans Michael
Mark Besterman Jeffrey
David Sternbach Daniel
Robert Peel Michael
Original Assignee
Glaxo Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Inc. filed Critical Glaxo Inc.
Publication of IS4092A publication Critical patent/IS4092A/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/66—Nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/18—Ethylenedioxybenzenes, not substituted on the hetero ring

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
IS4092A 1992-11-12 1993-11-08 Vatnsuppleysanlegar Camptothecin afleiður og aðferð til framleiðslu þeirra IS4092A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US97536392A 1992-11-12 1992-11-12
US97536492A 1992-11-12 1992-11-12

Publications (1)

Publication Number Publication Date
IS4092A true IS4092A (is) 1994-05-13

Family

ID=27130580

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4092A IS4092A (is) 1992-11-12 1993-11-08 Vatnsuppleysanlegar Camptothecin afleiður og aðferð til framleiðslu þeirra

Country Status (12)

Country Link
US (1) US6100273A (is)
EP (1) EP0673380A1 (is)
JP (1) JPH08503221A (is)
CN (1) CN1091742A (is)
AP (1) AP9300587A0 (is)
AU (1) AU5604594A (is)
CA (1) CA2148819A1 (is)
IS (1) IS4092A (is)
MX (1) MX9307011A (is)
MY (1) MY109296A (is)
SI (1) SI9300591A (is)
WO (1) WO1994011377A2 (is)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP9300587A0 (en) * 1992-11-12 1995-05-05 Glaxo Inc Water soluble camptothecin derivatives.
US5491237A (en) * 1994-05-03 1996-02-13 Glaxo Wellcome Inc. Intermediates in pharmaceutical camptothecin preparation
IT1269862B (it) * 1994-05-30 1997-04-15 Indena Spa Alcaloidi da mappia foetida, loro uso e formulazioni che li contengono
US5496952A (en) * 1995-02-07 1996-03-05 North Carolina State University Method of making asymmetric DE ring intermediates for the synthesis of camptothecin and camptothecin analogs
JPH08333370A (ja) * 1995-06-08 1996-12-17 Kyorin Pharmaceut Co Ltd 水に可溶な新規フルオロエチルカンプトテシン誘導体、及びその製造方法
US6559309B2 (en) 1996-11-01 2003-05-06 Osi Pharmaceuticals, Inc. Preparation of a camptothecin derivative by intramolecular cyclisation
US6207673B1 (en) 1997-03-12 2001-03-27 The University Of North Carolina At Chapel Hill Covalent conjugates of topoisomerase I and topoisomerase II inhibitors
CA2385528C (en) 1999-10-01 2013-12-10 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
US6288072B1 (en) * 1999-12-29 2001-09-11 Monroe E. Wall Camptothecin β-alanine esters with topoisomerase I inhibition
AU2001243515A1 (en) * 2000-03-08 2001-09-17 Rhode Island Hospital, A Lifespan Partner Combination drug therapy
US6825206B1 (en) * 2000-11-16 2004-11-30 Research Triangle Institute Camptothecin compounds with a thioether group
US6593334B1 (en) 2002-05-02 2003-07-15 The University Of North Carolina At Chapel Hill Camptothecin-taxoid conjugates as antimitotic and antitumor agents
US20040204435A1 (en) * 2003-04-09 2004-10-14 Joachim Liehr Alternating treatment with topoisomerase I and topoisomerase II inhibitors
PL1720540T3 (pl) 2004-02-18 2008-11-28 Gpc Biotech Ag Satraplatyna do leczenia odpornych i opornych nowotworów
EP2298292A3 (en) 2004-06-18 2011-08-10 Agennix USA Inc. Kinase inhibitors for treating cancers
UY30915A1 (es) * 2007-02-16 2008-09-02 Smithkline Beecham Corp Método de tratamiento de canceres
US20110129550A1 (en) * 2007-02-16 2011-06-02 Connie Erickson-Miller Cancer treatment method
US20110160130A1 (en) * 2007-02-16 2011-06-30 Connie Erickson-Miller Cancer treatment method
CN101888841B (zh) * 2007-10-09 2012-09-26 宾夕法尼亚大学理事会 血小板生成素受体激动剂(TpoRA)杀死急性人骨髓样白血病细胞
US8722886B1 (en) * 2012-11-13 2014-05-13 Bionumerik Pharmaceuticals, Inc. Methods for the total chemical synthesis of enantiomerically-pure 7-(2′-trimethylsilyl)ethyl camptothecin
KR20190090824A (ko) 2016-12-01 2019-08-02 글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 암을 치료하는 방법
CN119241554A (zh) * 2017-12-15 2025-01-03 四川科伦博泰生物医药股份有限公司 生物活性物偶联物及其制备方法和用途
CN110590796B (zh) * 2018-06-12 2022-07-15 青岛海洋生物医药研究院股份有限公司 喜树碱衍生物及其制备方法和应用
WO2021018941A1 (en) 2019-07-31 2021-02-04 Glaxosmithkline Intellectual Property Development Limited Methods of treating cancer
EP4429709A1 (en) * 2021-11-09 2024-09-18 Tubulis GmbH Conjugates comprising a phosphorus (v) and a camptothecin moiety
AU2023359114A1 (en) 2022-10-09 2025-04-24 LaNova Medicines Limited Compounds, compositions and methods

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4399282A (en) * 1979-07-10 1983-08-16 Kabushiki Kaisha Yakult Honsha Camptothecin derivatives
US4399276A (en) * 1981-01-09 1983-08-16 Kabushiki Kaisha Yakult Honsha 7-Substituted camptothecin derivatives
JPS6019790A (ja) * 1983-07-14 1985-01-31 Yakult Honsha Co Ltd 新規なカンプトテシン誘導体
US4894456A (en) * 1987-03-31 1990-01-16 Research Triangle Institute Synthesis of camptothecin and analogs thereof
US4943579A (en) * 1987-10-06 1990-07-24 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Water soluble prodrugs of camptothecin
US5004758A (en) * 1987-12-01 1991-04-02 Smithkline Beecham Corporation Water soluble camptothecin analogs useful for inhibiting the growth of animal tumor cells
JPH0615547B2 (ja) * 1988-01-20 1994-03-02 株式会社ヤクルト本社 新規なカンプトテシン誘導体
HU213136B (en) * 1990-08-14 1997-02-28 Kyorin Seiyaku Kk Process for producing fluoroethyl camptothecin derivatives and pharmaceutical compositions containing them
JP2848958B2 (ja) * 1990-09-28 1999-01-20 スミスクライン・ビーチャム・コーポレイション 水溶性カンプトテシン類似体、方法および手段
US5126351A (en) * 1991-01-24 1992-06-30 Glaxo Inc. Antitumor compounds
ATE136898T1 (de) * 1991-10-29 1996-05-15 Glaxo Wellcome Inc Wasserlösliche camptothecinderivate
US5559235A (en) * 1991-10-29 1996-09-24 Glaxo Wellcome Inc. Water soluble camptothecin derivatives
EP0556585A3 (en) * 1992-01-24 1993-09-01 Takeda Chemical Industries, Ltd. Condensed camptothecin derivatives their production and use as antitumor agents
US5342947A (en) * 1992-10-09 1994-08-30 Glaxo Inc. Preparation of water soluble camptothecin derivatives
AP9300587A0 (en) * 1992-11-12 1995-05-05 Glaxo Inc Water soluble camptothecin derivatives.

Also Published As

Publication number Publication date
AU5604594A (en) 1994-06-08
JPH08503221A (ja) 1996-04-09
EP0673380A1 (en) 1995-09-27
CA2148819A1 (en) 1994-05-26
CN1091742A (zh) 1994-09-07
WO1994011377A3 (en) 1994-08-04
MX9307011A (es) 1994-05-31
MY109296A (en) 1996-12-31
WO1994011377A2 (en) 1994-05-26
AP9300587A0 (en) 1995-05-05
SI9300591A (en) 1994-06-30
US6100273A (en) 2000-08-08

Similar Documents

Publication Publication Date Title
IS3805A (is) Amínósýruafleiður og aðferð við framleiðslu þeirra
IS3936A (is) Hliðstæð aðferð til framleiðslu á vatnsuppleysanlegum kamptóþesín afleiðum
NO306419B1 (no) Anordning og framgangsmaate for isolering av produksjonssone
NO177084C (no) Fremgangsmåte og anordning for kontinuerlig fremstilling av absorbente legemer
GB2249557B (en) Method for production of hop extracts and hop extracts obtained thereby
IS3718A7 (is) Amínóbenzodiazepines og aðferð til framleiðslu þess
NO305634B1 (no) FremgangsmÕte og anordning for kake-produksjon
DK50489A (da) Lyslederkonnektor og fremgangsmaade til fremstilling heraf
PL299368A1 (en) Novel derivatives of imidazopyridine and method of obtaining them
DK50889D0 (da) Cyclomaltodextringlucantransferase og fremgangsmaade til fremstilling heraf
IS3555A7 (is) Pyrrol-afleiður og aðferð til framleiðslu þeirra
IS3792A7 (is) Benzodiazepinones og aðferð til framleiðslu þess
DK0596122T3 (da) Fremgangsmåde til omvikling og omviklet genstand
IS3857A (is) Karboxýl-sýruafleiður og aðferð til framleiðslu þeirra
DK0635004T3 (da) 4-Diphenylmethylpiperidinderivater og fremgangsmåde til fremstilling deraf
IS1486B (is) Brennslukol og aðferð til framleiðslu þeirra
DK223089A (da) Lysdaemper og fremgangsmaade til fremstilling deraf
FI884747A7 (fi) Vesiliukoisia L-tyrosiinijohdannaisia ja menetelmä niiden valmistamiseksi
IS3951A (is) Cephalosporinafleiður, aðferð til framleiðslu þeirra og notkunar sem lyfja
IS4152A (is) Vatnsuppleysanlegar Camptothecin afleiður og aðferð til framleiðslu þeirra
DK272784D0 (da) 1,4-dihydropyridin-derivat, fremgangsmaade til fremstilling og farmaceutisk anvendelse deraf
IS1748B (is) Fóður og aðferð við framleiðslu þess
DK0512547T3 (da) Smertekontrollerende præparat og fremgangsmåde til fremstilling deraf
IS3725A7 (is) Amínósýruafleiður og aðferð til framleiðslu þeirra
NO940634L (no) Antiulcusmiddel og fremgangsmåte for fremstilling derav